The global artificial organs market was worth US$ 16.25 Billion in 2019 and is expected to reach US$ 37.7 Billion by 2030 at a CAGR of 8.0% through 2030. An artificial organ is a man-made organ tissue or a device that could replace the original human body organ and continue the same specific function as that of the organ replaced to enable the patient to continue having a normal life. Organ failure is one of the major causes of mortality across the world population. Bio-artificial organs can provide a prolonged life to the patients by substituting the failed/defective organs in the body. The replacement of the artificial organs is not only limited to the life support organs. Artificial organ implants can also be related to improving the individual’s quality of life. One of the ways to create artificial organs is to use tissue engineering or cell therapy techniques. Also, medical device solutions based on optical, mechanical, or electrical technological characteristics can be used.